Nurse Practitioner, Family · New York, NY
NPI
1598909954
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
525 E. 68th Street, Starr 3
New York, NY, 10065
Phone (646) 962-2065
Groups this clinician bills Medicare through
Medicare paid, 2024
$574K
16,848 services
Medicare patients, 2024
15
Average age 75
Drug cost, 2024
$2.1M
744 prescriptions
Company payments, 2025
$203
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley E Ray was code 36415 (venipuncture blood collection), 98 times for 12 patients. In total Ashley E Ray billed 16,848 services in 22 codes, and Medicare paid $574K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 98 | 12 | $8.65 | $848 |
| 99213 Office E&M - Established | Office | 97 | 12 | $74.20 | $7,197 |
| 96365 Intravenous Infusion, Hydration | Office | 47 | 11 | $52.33 | $2,460 |
By year: 2023 $102K for 4,627 services; 2024 $574K for 16,848 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 98 | 12 | $8.65 | $848 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashley E Ray prescribed most often to Medicare patients was Eliquis (Apixaban), with 158 prescriptions and refills. In total Ashley E Ray wrote 744 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 158 | 221 | 36 | $129K |
| Xarelto Rivaroxaban | 108 | 144 | 22 | $78K |
| Hydroxyurea Generic | 80 | 153 | 23 | $1,913 |
| Pegasys Peginterferon Alfa-2a | 75 | 75 | Under 11 | $307K |
| Promacta Eltrombopag Olamine | 52 | 53 | Under 11 | $395K |
| Jakafi Ruxolitinib Phosphate | 21 | 21 | Under 11 | $353K |
| Prednisone Generic | 18 | 24 | Under 11 | $90.14 |
| Folic Acid Generic | 15 | 44 | Under 11 | $187 |
| Doptelet Avatrombopag Maleate | 13 | 13 | Under 11 | $113K |
| Deferiprone Generic | 13 | 13 | Under 11 | $92K |
| Hydromorphone Hcl Generic | 12 | 12 | Under 11 | $346 |
| Diphenhydramine Hcl Generic | 12 | 12 | Under 11 | $27.85 |
| Mycophenolate Mofetil Generic | 12 | 20 | Under 11 | $723 |
| Hydroxychloroquine Sulfate Generic | 12 | 12 | Under 11 | $153 |
| Adakveo Crizanlizumab-Tmca | 12 | 12 | Under 11 | $77K |
Brand drugs: 484 claims; generic drugs: - claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley E Ray $203 ($203 in general payments such as food, travel and fees) from 4 companies. The largest payer was Genzyme Corporation with $68.79.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.